Awake craniotomies for epileptic gliomas: intraoperative and postoperative seizure control and prognostic factors

Yu Chi Wang, Cheng Chi Lee, Hirokazu Takami, Stephanie Shen, Ko Ting Chen, Kuo Chen Wei, Min Hsien Wu, Gregory Alan Worrell, Pin Yuan Chen

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Purpose: Awake craniotomy is well-established for tumors resected in eloquent brain areas. Whether awake craniotomy provides improved seizure control in patients with epileptic gliomas has not been well evaluated. This study analyzed the incidence, risk factors and outcome of seizures during and following awake craniotomies for patients presenting with epilepsy and glioma. Methods: Forty-one patients undergoing awake craniotomies for epileptic gliomas were retrospectively analyzed. Postoperative seizure was defined as either early (postoperative day 7 + before) or late onset (after postoperative day 7). Neurologic function was assessed with modified Rankin Scales (mRS) and seizure outcome was assessed using International League Against Epilepsy (ILAE) classification. Multivariable logistic regression was used for clinical variables associated with postoperative seizures. Results: Three patients (7.3%) had intraoperative seizures however did not fail the awake craniotomies. Mean mRS before and after the awake craniotomies were 2.4 and 2.1, respectively (P = 0.032). Fourteen (34.1%) patients had early seizures, which caused longer hospitalization than those without early seizures (P = 0.03). Surgical resection to isocitrate dehydrogenase 1 (IDH1) mutation tumors, comparing to IDH1 wild type tumors, caused better postoperative seizure control. 6-month late seizure freedom was achieved in 33 patients (80.5%). Early seizure recurrence (odds ratio = 30.75; P = 0.039) and postoperative mRS ≥ 3 (odds ratio = 7.00; P = 0.047) were independent risk factors for late seizures. Conclusions: Intraoperative seizures could be well-controlled during awake craniotomies. Early postoperative seizures extended hospitalization and strongly predicted late seizure recurrence. Awake craniotomies benefited long-term seizure control in patients with epileptic gliomas.

Original languageEnglish (US)
JournalJournal of neuro-oncology
DOIs
StatePublished - Jan 1 2019

Fingerprint

Craniotomy
Glioma
Seizures
Isocitrate Dehydrogenase
Epilepsy
Hospitalization
Odds Ratio
Recurrence
Neoplasms
Nervous System

Keywords

  • Awake craniotomy
  • Epilepsy
  • Glioma
  • Seizure

ASJC Scopus subject areas

  • Oncology
  • Neurology
  • Clinical Neurology
  • Cancer Research

Cite this

Awake craniotomies for epileptic gliomas : intraoperative and postoperative seizure control and prognostic factors. / Wang, Yu Chi; Lee, Cheng Chi; Takami, Hirokazu; Shen, Stephanie; Chen, Ko Ting; Wei, Kuo Chen; Wu, Min Hsien; Worrell, Gregory Alan; Chen, Pin Yuan.

In: Journal of neuro-oncology, 01.01.2019.

Research output: Contribution to journalArticle

Wang, Yu Chi ; Lee, Cheng Chi ; Takami, Hirokazu ; Shen, Stephanie ; Chen, Ko Ting ; Wei, Kuo Chen ; Wu, Min Hsien ; Worrell, Gregory Alan ; Chen, Pin Yuan. / Awake craniotomies for epileptic gliomas : intraoperative and postoperative seizure control and prognostic factors. In: Journal of neuro-oncology. 2019.
@article{d37e577569c84051807462d87b260cf3,
title = "Awake craniotomies for epileptic gliomas: intraoperative and postoperative seizure control and prognostic factors",
abstract = "Purpose: Awake craniotomy is well-established for tumors resected in eloquent brain areas. Whether awake craniotomy provides improved seizure control in patients with epileptic gliomas has not been well evaluated. This study analyzed the incidence, risk factors and outcome of seizures during and following awake craniotomies for patients presenting with epilepsy and glioma. Methods: Forty-one patients undergoing awake craniotomies for epileptic gliomas were retrospectively analyzed. Postoperative seizure was defined as either early (postoperative day 7 + before) or late onset (after postoperative day 7). Neurologic function was assessed with modified Rankin Scales (mRS) and seizure outcome was assessed using International League Against Epilepsy (ILAE) classification. Multivariable logistic regression was used for clinical variables associated with postoperative seizures. Results: Three patients (7.3{\%}) had intraoperative seizures however did not fail the awake craniotomies. Mean mRS before and after the awake craniotomies were 2.4 and 2.1, respectively (P = 0.032). Fourteen (34.1{\%}) patients had early seizures, which caused longer hospitalization than those without early seizures (P = 0.03). Surgical resection to isocitrate dehydrogenase 1 (IDH1) mutation tumors, comparing to IDH1 wild type tumors, caused better postoperative seizure control. 6-month late seizure freedom was achieved in 33 patients (80.5{\%}). Early seizure recurrence (odds ratio = 30.75; P = 0.039) and postoperative mRS ≥ 3 (odds ratio = 7.00; P = 0.047) were independent risk factors for late seizures. Conclusions: Intraoperative seizures could be well-controlled during awake craniotomies. Early postoperative seizures extended hospitalization and strongly predicted late seizure recurrence. Awake craniotomies benefited long-term seizure control in patients with epileptic gliomas.",
keywords = "Awake craniotomy, Epilepsy, Glioma, Seizure",
author = "Wang, {Yu Chi} and Lee, {Cheng Chi} and Hirokazu Takami and Stephanie Shen and Chen, {Ko Ting} and Wei, {Kuo Chen} and Wu, {Min Hsien} and Worrell, {Gregory Alan} and Chen, {Pin Yuan}",
year = "2019",
month = "1",
day = "1",
doi = "10.1007/s11060-019-03131-0",
language = "English (US)",
journal = "Journal of Neuro-Oncology",
issn = "0167-594X",
publisher = "Kluwer Academic Publishers",

}

TY - JOUR

T1 - Awake craniotomies for epileptic gliomas

T2 - intraoperative and postoperative seizure control and prognostic factors

AU - Wang, Yu Chi

AU - Lee, Cheng Chi

AU - Takami, Hirokazu

AU - Shen, Stephanie

AU - Chen, Ko Ting

AU - Wei, Kuo Chen

AU - Wu, Min Hsien

AU - Worrell, Gregory Alan

AU - Chen, Pin Yuan

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Purpose: Awake craniotomy is well-established for tumors resected in eloquent brain areas. Whether awake craniotomy provides improved seizure control in patients with epileptic gliomas has not been well evaluated. This study analyzed the incidence, risk factors and outcome of seizures during and following awake craniotomies for patients presenting with epilepsy and glioma. Methods: Forty-one patients undergoing awake craniotomies for epileptic gliomas were retrospectively analyzed. Postoperative seizure was defined as either early (postoperative day 7 + before) or late onset (after postoperative day 7). Neurologic function was assessed with modified Rankin Scales (mRS) and seizure outcome was assessed using International League Against Epilepsy (ILAE) classification. Multivariable logistic regression was used for clinical variables associated with postoperative seizures. Results: Three patients (7.3%) had intraoperative seizures however did not fail the awake craniotomies. Mean mRS before and after the awake craniotomies were 2.4 and 2.1, respectively (P = 0.032). Fourteen (34.1%) patients had early seizures, which caused longer hospitalization than those without early seizures (P = 0.03). Surgical resection to isocitrate dehydrogenase 1 (IDH1) mutation tumors, comparing to IDH1 wild type tumors, caused better postoperative seizure control. 6-month late seizure freedom was achieved in 33 patients (80.5%). Early seizure recurrence (odds ratio = 30.75; P = 0.039) and postoperative mRS ≥ 3 (odds ratio = 7.00; P = 0.047) were independent risk factors for late seizures. Conclusions: Intraoperative seizures could be well-controlled during awake craniotomies. Early postoperative seizures extended hospitalization and strongly predicted late seizure recurrence. Awake craniotomies benefited long-term seizure control in patients with epileptic gliomas.

AB - Purpose: Awake craniotomy is well-established for tumors resected in eloquent brain areas. Whether awake craniotomy provides improved seizure control in patients with epileptic gliomas has not been well evaluated. This study analyzed the incidence, risk factors and outcome of seizures during and following awake craniotomies for patients presenting with epilepsy and glioma. Methods: Forty-one patients undergoing awake craniotomies for epileptic gliomas were retrospectively analyzed. Postoperative seizure was defined as either early (postoperative day 7 + before) or late onset (after postoperative day 7). Neurologic function was assessed with modified Rankin Scales (mRS) and seizure outcome was assessed using International League Against Epilepsy (ILAE) classification. Multivariable logistic regression was used for clinical variables associated with postoperative seizures. Results: Three patients (7.3%) had intraoperative seizures however did not fail the awake craniotomies. Mean mRS before and after the awake craniotomies were 2.4 and 2.1, respectively (P = 0.032). Fourteen (34.1%) patients had early seizures, which caused longer hospitalization than those without early seizures (P = 0.03). Surgical resection to isocitrate dehydrogenase 1 (IDH1) mutation tumors, comparing to IDH1 wild type tumors, caused better postoperative seizure control. 6-month late seizure freedom was achieved in 33 patients (80.5%). Early seizure recurrence (odds ratio = 30.75; P = 0.039) and postoperative mRS ≥ 3 (odds ratio = 7.00; P = 0.047) were independent risk factors for late seizures. Conclusions: Intraoperative seizures could be well-controlled during awake craniotomies. Early postoperative seizures extended hospitalization and strongly predicted late seizure recurrence. Awake craniotomies benefited long-term seizure control in patients with epileptic gliomas.

KW - Awake craniotomy

KW - Epilepsy

KW - Glioma

KW - Seizure

UR - http://www.scopus.com/inward/record.url?scp=85062093227&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062093227&partnerID=8YFLogxK

U2 - 10.1007/s11060-019-03131-0

DO - 10.1007/s11060-019-03131-0

M3 - Article

C2 - 30805752

AN - SCOPUS:85062093227

JO - Journal of Neuro-Oncology

JF - Journal of Neuro-Oncology

SN - 0167-594X

ER -